Impel Neuropharma Inc (IMPL) Financials

$0.02

$0.00 (-21.50%)

As on 16-Feb-2024 09:30EDT

Market cap

$6 Mln

Revenue (TTM)

$21 Mln

P/E Ratio

--

P/B Ratio

18.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	20.99	12.65	0.67	--	--	--
Cost of Revenue	9.95	6.50	0.69	--	--	--
Gross Profit	11.04	6.16	-0.02	--	--	--
Operating Expenses	81.14	89.34	71.46	45.33	41.57	--
Operating Profit (EBIT)	-70.11	-83.18	-71.49	-45.33	-41.57	--
Other Income	--	--	-5.05	--	--	--
Profit before Tax	-74.28	-106.31	-76.53	-45.80	-41.83	--
Provision for Tax	24.27	23.13	0.00	0.00	0.03	--
Profit after Tax (Net Income)	-96.11	-129.44	-76.54	-45.80	-41.86	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-23.04	-106.31	-76.67	-46.32	-42.36	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-91.91	-44.16	52.51	-133.50	-91.70	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.24	110.54	29.45	135.03	125.65	--
Current Liabilities	124.74	22.16	15.95	10.53	8.32	--
Total Liabilities	159.82	88.55	97.91	12.06	42.27	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	11.65	8.74	3.34	3.89	2.74	--
Current Assets	23.43	79.81	94.58	8.17	39.53	--
Total Assets	159.82	88.55	97.91	12.06	42.27	--
Total Debt*	114.80	51.19	29.45	8.41	--	--
Net Current Assets	-101.32	57.65	78.62	-2.35	31.20	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-93.64	-66.36	-39.18	-36.49	--
Cash Flow from Investing Activities	--	-1.38	-0.41	-1.78	-1.52	--
Cash from Financing Activities	--	67.46	147.89	11.06	0.02	--
Net Cash Inflow / Outflow	--	--	81.12	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-4.05	-5.45	-3.32	-3.49	--	--
Cash EPS ($)	--	-5.40	-3.27	-3.40	--	--
Adjusted Book Value ($)	--	--	2.28	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.94	-2.88	-2.98	--	--
Free Cash Flow per Share ($)	--	-4.00	-2.89	-3.12	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-290.92	354.90	42.25	--	--
ROE (%)	--	-3,099.99	189.00	40.67	--	--
ROA (%)	-67.46	-138.84	-139.19	-168.61	--	--
EBIT Margin (%)	-338.27	-657.48	-10,701.50	--	--	--
Net Margin (%)	-457.97	-1,023.08	1,747.40	--	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	155.29	17.94	--	--	--	--
EBIT Growth (%)	20.95	-16.36	-57.69	-9.07	--	--
Net Profit Growth (%)	23.92	-69.12	-67.12	-9.41	--	--
EPS Growth (%)	25.29	-0.64	0.05	--	--	--
Book Value Growth (%)	-311.65	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.69	-2.60	--	--	--
Price / Book Value	18.46	-2.02	3.79	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.68	-0.97	-1.99	--	--	--
Close Price ($)	0.43	3.75	8.63	--	--	--
High Price ($)	5.39	10.75	34.75	--	--	--
Low Price ($)	0.29	2.52	6.90	--	--	--
Market Cap ($ Cr)	5.76	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-1.16	0.56	-0.06	--	--
Short term debt to equity ratio	-1.22	-0.03	--	0.00	--	--
Current Ratio	0.19	3.60	5.93	0.78	4.75	--
Quick Ratio	0.13	3.22	5.75	0.80	4.77	--
Interest Coverage	-1.79	-6.01	-18.05	-97.91	-158.05	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	31.41	58.84	202.40	--	--	--
Asset Turnover	0.15	0.14	0.01	--	--	--
Receivable days	--	126.97	432.23	--	--	--
Inventory Days	--	316.35	685.83	--	--	--
Payable days	--	350.32	2,822.89	--	--	--
Cash Conversion Cycle	--	93.00	-1,704.83	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.